Compare Heron Therapeutics Inc (HRTX) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Western Union Co — how do they compare? Heron Therapeutics Inc trades at $0.35 (market cap $61.47M), while Western Union Co trades at $6.97 (market cap $2.20B). The key difference: Western Union Co is far larger — about 35.8× Heron Therapeutics Inc's market cap, and Western Union Co pays a 13.33% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | WU | |
|---|---|---|
Market Cap | $61.47M | $2.20B |
Sector | Health | Technology |
52-Week High | $1.49 | $10.28 |
52-Week Low | $0.32 | $6.36 |
Enterprise Value | $168.21M | $2.10B |
Dividend Yield | — | 13.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.
The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.
Western Union (WU) trades at $7.03, down 0.71% on the day, with a bearish technical outlook and recent earnings misses. The stock shows low valuation multiples (P/E 5.69, P/S 0.56) and strong profitability metrics (ROE 43.97%), but revenue has declined from $4.5B in 2022 to $4.05B in 2025. Recent news highlights challenges in retail money transfers and a new digital initiative with Rain.
The investment outlook is cautious due to declining revenue, earnings volatility, and bearish analyst sentiment. Opportunities exist from deep value metrics and dividend yield, but risks include competitive pressures and execution challenges in digital transformation. The consensus price target is $7.14, suggesting limited upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
